Manual Therapy Treatment for Myofascial Pain

This study has been completed.
Sponsor:
Information provided by:
Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT01381380
First received: June 23, 2011
Last updated: June 24, 2011
Last verified: November 2007
  Purpose

This study is a pain intensity evaluation in patients with myofascial pain submitted kinesitherapy after trigger point injection.


Condition Intervention
Myofascial Pain Syndromes
Procedure: Manual therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Manual Therapy After Trigger Point Injection for Myofascial Pain Syndrome

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Pain intensity [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    once a week for 8 weeks (T1 to T8)


Enrollment: 30
Study Start Date: November 2006
Study Completion Date: December 2009
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
single-arm studies
Manual therapy for one group
Procedure: Manual therapy
Manual therapy, once a week for 8 weeks
Other Names:
  • massage
  • finger pressure
  • myofascial release
  • mobilization

Detailed Description:

Randomized prospective study conducted on 30 patients of both genders ranging in age from 18 to 60 years, with neck and shoulder girdle Myofascial Pain Syndrome (MFS), with a duration of ≥ 4 months and pain intensity ≥ 4.

Trigger point injection of 1 mL 0.25% bupivacaine at each point, once a week for 8 weeks (T1 to T8).

Group 1: kinesiotherapy once a week for 8 weeks Group 2: not submitted to kinesiotherapy Evaluation of pain intensity on the first assessment (T0) and after 1, 2, 3, 4, 5, 6, 7, 8, and 9 weeks

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • myofascial pain of neck and shoulder girdle, lasting ≥ 4 months, pain intensity ≥ 4.

Exclusion Criteria:

  • arrhythmia
  • heart block
  • coagulopathy
  • cognitive alterations and infection at the site
  • patients using anticoagulants, and pregnant women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01381380

Locations
Brazil
Setor de Dor
São Paulo, Brazil, 04023-062
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Director: Rioko K Sakata, PhD Universidade Federal de São Paulo
  More Information

No publications provided

Responsible Party: Rioko Kimiko Sakata, Universidade Federal de São Paulo
ClinicalTrials.gov Identifier: NCT01381380     History of Changes
Other Study ID Numbers: 1276
Study First Received: June 23, 2011
Last Updated: June 24, 2011
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Federal University of São Paulo:
myofascial pain
trigger point injection
manual therapy

Additional relevant MeSH terms:
Myofascial Pain Syndromes
Fibromyalgia
Somatoform Disorders
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014